The Texas Rangers’ “gamble” of signing Jacob deGrom to a five-year, $185 million (about 24.11 billion won) contract with the unfounded hope that his health problems would magically disappear appears to have failed.
“DeGrom will undergo surgery to repair damage to the ulnar collateral ligament in his right elbow,” the Rangers of Major League Baseball announced on 6 June (local time). It is widely believed that he will undergo an elbow ligament reconstruction, known locally as Tommy John surgery.
The Rangers are owed $30 million (K391 million) for DeGrom, who went 2-0 with a 2.67 ERA in 30.1 innings pitched in six starts this season. He could return in a year at the earliest if he undergoes Tommy John surgery. Given that he has already had Tommy John surgery once before, in 2010, before making his big league debut, and that he turns 35 on the 19th of this month, there is a good chance he will miss the entirety of next year. His salary for next year is $40 million (K521 million).스포츠토토
Worst case scenario for the Rangers, they’d be throwing away the first two years of a five-year, $70 million contract.
According to USA Today, there is no insurance in place to cover an injury exit for DeGrom.
Since making his debut with the New York Mets in 2014, deGrom has developed into one of the league’s most dominant pitchers, with his average velocity rising significantly to 96 miles per hour (154.5 kilometres per hour) in 2018.
After winning the National League Cy Young Award in 2018 with a 10-9 record, 1.70 ERA, and 269 strikeouts, he followed that up with an 11-8 record, 2.43 ERA, and 255 strikeouts in 2019, edging out Hyun-jin Ryu (36, Toronto Blue Jays) for his second straight Cy Young Award.
But in 2020, he was plagued by a series of injuries.
Elbow inflammation, forearm tightness, wrist pain and tightness, neck tightness, and a stress reaction in his shoulder blade, among other injuries, drastically reduced the number of times he took the mound. He started just 12 games in 2020, 15 in 2021, and 11 in 2022. In all, he started just 44 games and threw 254.2 innings from 2020-23.
DeGrom was eligible for free agency after the 2022 season, but his original team, the Mets, who had invested aggressively in him, did not offer him a contract. It became the best move of Mets owner Steve Cohen’s baseball career.
It’s unclear if DeGrom will make a successful return from surgery. His injury history is so storied that there’s no guarantee he’ll stay healthy and in the starting rotation for the remainder of his contract.
On 28 April against the New York Yankees, he was removed from the game in the fourth inning with elbow pain and never took the mound again. Texas’ gamble of spending $24 million in hopes of keeping DeGrom healthy for five years proved unsuccessful just three weeks into the season.